FDA Update on the WATCHMAN® Left Atrial Appendage (LAA) Closure Device to Prevent Strokes in Atrial Fibrillation (Afib) Patients

FDA Update on the WATCHMAN® Left Atrial Appendage (LAA) Closure Device to Prevent Strokes in Atrial Fibrillation Patients

Anticoagulation
Medication
Stroke
Study
Treatment

March 18, 2010

There was an update today on the long-awaited FDA status of Atritech's WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced …

Subscribe to Our Newsletter

Archives

FDA Update on the WATCHMAN® Left Atrial Appendage (LAA) Closure Device to Prevent Strokes in Atrial Fibrillation Patients